Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy | MicrobiomeTrials← Back to trialsNCT00977977
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2010-12-22Est. Completion: 2027-12-31
Enrollment target: 30 participants Locations- National Naval Medical Center, Bethesda, Maryland, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Nephrotic SyndromeLipodystrophyMetabolic SyndromeHealthy VolunteerDiabetesMetabolic Associated Steatotic Liver Disease
Background:
Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn mo…
Bethesda, United StatesEst. completion Feb 1, 2030
Focal Segmental Glomerulosclerosis
PODOMOUNT-pFSGS
This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosc…
Alabaster, United StatesEst. completion Dec 27, 2028